News
In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...
12h
TipRanks on MSNEli Lilly’s Promising Cancer Therapy Study: A Potential Game-Changer?
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is conducting a clinical ...
With the price of Mounjaro set to almost triple in the UK, there are fears more and more people will turn to counterfeits.
Longer-term data show that donanemab’s cognitive benefits continue to grow over time, and earlier initiation reduces the risk for progression, with no new safety signals.
Indianapolis: Eli Lilly and Company has announced that Anne White, executive vice president and president, Lilly Neuroscience ...
15h
MarketBeat on MSNOzempic Boom: Hims & Eli Lilly Lead Healthcare Bets
Most investors have noticed that most stocks in the healthcare sector have declined to levels not seen in a while, making ...
Johnson & Johnson announces a $2 billion North Carolina manufacturing expansion as part of a broader U.S. onshore ...
What goes up must come down — here are the major drugs falling the hardest at the top companies so far this year.
When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...
Fat jabbers all over the country are in meltdown following the news that Mounjaro, the most popular and effective of all the ...
Novo Nordisk faces potential layoffs after a period of rapid expansion fueled by the success of Wegovy. The company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results